{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:38:33Z","timestamp":1761896313246,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,4,16]],"date-time":"2016-04-16T00:00:00Z","timestamp":1460764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370637"],"award-info":[{"award-number":["81370637"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00432-016-2158-8","type":"journal-article","created":{"date-parts":[[2016,4,16]],"date-time":"2016-04-16T11:51:28Z","timestamp":1460807488000},"page":"1549-1555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Molecular monitoring of tyrosine kinase inhibitor therapy of chronic myeloid leukemia in China"],"prefix":"10.1007","volume":"142","author":[{"given":"Qian","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert Peter","family":"Gale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,16]]},"reference":[{"key":"2158_CR1","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","volume":"122","author":"M Baccarani","year":"2013","unstructured":"Baccarani M, Deininger MW, Rosti G et al (2013) European LeukemiaNet recommendations for the management of chronic myeloid leukemia. Blood 122:872\u2013884","journal-title":"Blood"},{"key":"2158_CR2","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1185\/03007995.2012.741577","volume":"28","author":"L Chen","year":"2012","unstructured":"Chen L, Guerin A, Xie J et al (2012) Monitoring and switching patterns of patients with chronic myeloid leukemia treated with imatinib in community settings: a chart review analysis. Curr Med Res Opin 28:1831\u20131839","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"2158_CR3","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1038\/leu.2012.104","volume":"26","author":"NC Cross","year":"2012","unstructured":"Cross NC, White HE, M\u00fcller MC, Saglio G, Hochhaus A (2012) Standardized definitions of molecular response in chronic myeloid leukemia. Leukemia 26(10):2172\u20132175","journal-title":"Leukemia"},{"issue":"Suppl 2","key":"2158_CR4","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1007\/s00277-015-2315-1","volume":"94","author":"NC Cross","year":"2015","unstructured":"Cross NC, Hochhaus A, M\u00fcller MC (2015a) Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization. Ann Hematol 94(Suppl 2):S219\u2013S225","journal-title":"Ann Hematol"},{"issue":"5","key":"2158_CR5","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/leu.2015.29","volume":"29","author":"NC Cross","year":"2015","unstructured":"Cross NC, White HE, Colomer D et al (2015b) Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia. Leukemia 29(5):999\u20131003","journal-title":"Leukemia"},{"issue":"Suppl","key":"2158_CR6","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.clml.2015.03.015","volume":"15","author":"D Egan","year":"2015","unstructured":"Egan D, Radich J (2015) Prognosis and molecular monitoring in chronic myeloid leukemia. Clin Lymphoma Myeloma Leuk 15(Suppl):S109\u2013S113","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"12","key":"2158_CR7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.clml.2015.08.088","volume":"15","author":"SL Goldberg","year":"2015","unstructured":"Goldberg SL (2015) Monitoring chronic myeloid leukemia in the real world: gaps and opportunities. Clin Lymphoma Myeloma Leuk 15(12):711\u2013714","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2158_CR8","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1185\/03007995.2013.812034","volume":"29","author":"SL Goldberg","year":"2013","unstructured":"Goldberg SL, Chen L, Guerin A et al (2013) Association between molecular monitoring and long-term outcomes in chronic myelogenous leukemia patients treated with first line imatinib. Cur Med Res Opin 29:1075\u20131082","journal-title":"Cur Med Res Opin"},{"key":"2158_CR9","doi-asserted-by":"crossref","unstructured":"Goldberg SL, Cortes JE, Gambacorti-Passerini C et al (2014) Cytogenetic and molecular testing in patients with chronic myeloid leukemia in a prospective observational study (SIMPLICITY). J Clin Oncol (ASCO Annual Meeting Abstracts) 32; abstract 7050","DOI":"10.1200\/jco.2014.32.15_suppl.7050"},{"key":"2158_CR10","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1200\/JOP.2014.001099","volume":"11","author":"SL Goldberg","year":"2015","unstructured":"Goldberg SL, Akard LP, Dugan MJ, Faderl S, Pecora AL (2015) Barriers to physician adherence to evidence-based monitoring guidelines in chronic myelogenous leukemia. J Oncol Pract 11:e398\u2013e404","journal-title":"J Oncol Pract"},{"key":"2158_CR11","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1185\/03007995.2014.904281","volume":"30","author":"A Gu\u00e9rin","year":"2014","unstructured":"Gu\u00e9rin A, Chen L, Dea K, Wu EQ, Goldberg SL (2014a) Association between regular molecular monitoring and tyrosine kinase inhibitor therapy adherence in chronic myelogenous leukemia in the chronic phase. Curr Med Res Opin 30:1345\u20131352","journal-title":"Curr Med Res Opin"},{"key":"2158_CR12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3111\/13696998.2013.862251","volume":"17","author":"A Gu\u00e9rin","year":"2014","unstructured":"Gu\u00e9rin A, Chen L, Dea K, Wu EQ, Goldberg SL (2014b) Economic benefits of adequate molecular monitoring in patients with chronic myelogenous leukemia. J Med Econ 17:89\u201398","journal-title":"J Med Econ"},{"key":"2158_CR13","unstructured":"National Comprehensive Cancer Network (2015) NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia version 1 (2016) Fort Washington PA. National Comprehensive Care Network. 2015. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cml.pdf . Accessed 26 Mar 2016"},{"issue":"5 Suppl","key":"2158_CR14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.6004\/jnccn.2014.0197","volume":"12","author":"JP Radich","year":"2014","unstructured":"Radich JP (2014) Monitoring molecular response to tyrosine kinase therapy in chronic myelogenous leukemia. J Natl Compr Cancer Netw 12(5 Suppl):817\u2013820","journal-title":"J Natl Compr Cancer Netw"},{"key":"2158_CR15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1185\/03007995.2013.858621","volume":"30","author":"MN Saleh","year":"2014","unstructured":"Saleh MN, Haislip S, Sharpe J et al (2014) Assessment of treatment and monitoring patterns and subsequent outcomes among patients with chronic myeloid leukemia treated with imatinib in a community setting. Curr Med Res Opin 30:529\u2013536","journal-title":"Curr Med Res Opin"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-016-2158-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-016-2158-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-016-2158-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T15:41:17Z","timestamp":1567784477000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-016-2158-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,16]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["2158"],"URL":"https:\/\/doi.org\/10.1007\/s00432-016-2158-8","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"type":"print","value":"0171-5216"},{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[2016,4,16]]}}}